NIH consensus development conference: Inhaled nitric oxide therapy for premature infants.

NIH consensus and state-of-the-science statements

Volumn 27, Issue 5, 2010, Pages 1-34

  Cole, F Sessions ^a   Alleyne, Claudia ^b   Barks, John D E ^b   Boyle, Robert J ^b   Carroll, John L ^b   Dokken, Deborah ^b   Edwards, William H ^b   Georgieff, Michael ^b   Gregory, Katherine ^b   Johnston, Michael V ^b   Kramer, Michael ^b   Mitchell, Christine ^b   Neu, Josef ^b   Pursley, DeWayne M ^b   Robinson, Walter ^b   Rowitch, David H ^b  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; NITRIC OXIDE;

CLINICAL TRIAL (TOPIC); CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PRACTICE GUIDELINE; PREMATURITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NITRIC OXIDE; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84877930336     PISSN: None     EISSN: 15530779     Source Type: None    
DOI: None     Document Type: Review

References (0)